Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-17-002109
Filing Date
2017-02-23
Accepted
2017-02-23 09:16:47
Documents
91
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 OGXI-10K-20161231 ogxi-10k_20161231.htm 10-K 4120757
2 EX-21.1 ogxi-ex211_9.htm EX-21.1 1034
3 EX-23.1 ogxi-ex231_666.htm EX-23.1 13254
4 EX-31.1 ogxi-ex311_11.htm EX-31.1 8169
5 EX-31.2 ogxi-ex312_10.htm EX-31.2 8695
6 EX-32.1 ogxi-ex321_6.htm EX-32.1 3752
7 EX-32.2 ogxi-ex322_8.htm EX-32.2 3842
8 GRAPHIC g201702222044204696995.jpg GRAPHIC 35055
  Complete submission text file 0001564590-17-002109.txt   14402803

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ogxi-20161231.xml EX-101.INS 3496004
10 XBRL TAXONOMY EXTENSION SCHEMA ogxi-20161231.xsd EX-101.SCH 84773
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogxi-20161231_cal.xml EX-101.CAL 57478
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogxi-20161231_def.xml EX-101.DEF 319916
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogxi-20161231_lab.xml EX-101.LAB 597114
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogxi-20161231_pre.xml EX-101.PRE 498934
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-80623 | Film No.: 17630958
SIC: 2835 In Vitro & In Vivo Diagnostic Substances